NV-5138
98%
- Product Code: 220321
CAS:
2095886-80-7
| Molecular Weight: | 181.18 g./mol | Molecular Formula: | C₇H₁₃F₂NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
NV-5138 is a first-in-class small molecule that acts as a potent activator of the mTORC1 signaling pathway through selective modulation of the amino acid transporter SLC7A5. It is primarily investigated for its rapid and sustained antidepressant effects, particularly in treatment-resistant depression. Unlike traditional antidepressants that may take weeks to show effects, NV-5138 has demonstrated the ability to produce significant improvements in mood and depressive symptoms within hours to days in preclinical and early clinical studies.
The compound crosses the blood-brain barrier efficiently and targets brain regions involved in mood regulation, such as the prefrontal cortex and hippocampus. By enhancing synaptic protein synthesis and promoting neuronal resilience, NV-5138 supports neuroplasticity, which is often impaired in mood disorders.
Due to its unique mechanism of action and rapid onset, NV-5138 holds promise as a therapeutic option for major depressive disorder and potentially other neuropsychiatric conditions involving impaired mTOR signaling, such as cognitive dysfunction or chronic stress-related disorders. Clinical development is ongoing to evaluate its safety, efficacy, and long-term benefits in diverse patient populations.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿22,470.00 |
+
-
|
| 10mg | 10-20 days | ฿35,970.00 |
+
-
|
| 200mg | 10-20 days | ฿0.00 |
+
-
|
NV-5138
NV-5138 is a first-in-class small molecule that acts as a potent activator of the mTORC1 signaling pathway through selective modulation of the amino acid transporter SLC7A5. It is primarily investigated for its rapid and sustained antidepressant effects, particularly in treatment-resistant depression. Unlike traditional antidepressants that may take weeks to show effects, NV-5138 has demonstrated the ability to produce significant improvements in mood and depressive symptoms within hours to days in preclinical and early clinical studies.
The compound crosses the blood-brain barrier efficiently and targets brain regions involved in mood regulation, such as the prefrontal cortex and hippocampus. By enhancing synaptic protein synthesis and promoting neuronal resilience, NV-5138 supports neuroplasticity, which is often impaired in mood disorders.
Due to its unique mechanism of action and rapid onset, NV-5138 holds promise as a therapeutic option for major depressive disorder and potentially other neuropsychiatric conditions involving impaired mTOR signaling, such as cognitive dysfunction or chronic stress-related disorders. Clinical development is ongoing to evaluate its safety, efficacy, and long-term benefits in diverse patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :